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Abstract
Wnt Planar Cell Polarity (PCP) signaling is a universal regulator of polarity in epithelial cells, but it regulates axon outgrowth
in neurons, suggesting the existence of axonal modulators of Wnt-PCP activity. The Amyloid precursor proteins (APPs) are
intensely investigated because of their link to Alzheimer’s disease (AD). APP’s in vivo function in the brain and the
mechanisms underlying it remain unclear and controversial. Drosophila possesses a single APP homologue called APP Like,
or APPL. APPL is expressed in all neurons throughout development, but has no established function in neuronal
development. We therefore investigated the role of Drosophila APPL during brain development. We find that APPL is
involved in the development of the Mushroom Body ab neurons and, in particular, is required cell-autonomously for the b-
axons and non-cell autonomously for the a-axons growth. Moreover, we find that APPL is a modulator of the Wnt-PCP
pathway required for axonal outgrowth, but not cell polarity. Molecularly, both human APP and fly APPL form complexes
with PCP receptors, thus suggesting that APPs are part of the membrane protein complex upstream of PCP signaling.
Moreover, we show that APPL regulates PCP pathway activation by modulating the phosphorylation of the Wnt adaptor
protein Dishevelled (Dsh) by Abelson kinase (Abl). Taken together our data suggest that APPL is the first example of a
modulator of the Wnt-PCP pathway specifically required for axon outgrowth.
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Introduction
The Wnt Planar Cell Polarity (PCP) pathway is a highly
conserved regulator of cellular orientation within the plane of an
epithelium [1,2]. Genetic and molecular studies in Drosophila
indicate Disheveled (Dsh), a cytoplasmic transducer of Wnt
signaling; Frizzled (Fz), a seven-transmembrane receptor for Wnt
ligands; and Van Gogh (Vang), a four-pass transmembrane
protein, as core Wnt-PCP proteins. Intriguingly, the Wnt-PCP
pathway regulates axon outgrowth rather than neuronal polarity
during brain development of both vertebrates and Drosophila [3–5].
The Amyloid Precursor Protein (APP) is a member of a highly
conserved family of type I transmembrane proteins that includes
APP, APLP1, and APLP2 [6] in mammals and APP-Like, or
APPL, in Drosophila melanogaster [7]. APP proteins show not only
structural but also functional conservation, as exemplified by the
ability of human APP to rescue behavioral phenotypes of APPL
null flies [8]. APP is the subject of intense research because of
genetic and biochemical links to Alzheimer’s disease (AD),
whereby the proteolytic processing of APP generates the Amyloid
Beta peptide whose accumulation in the brain is widely thought to
induce neurodegeneration [9–12]. Despite these efforts, the
normal physiological function of APP in vivo in the nervous
system remains elusive and highly controversial. This is due to the
lack of a consensus over the neuronal phenotypes in null mutant
animals and the mechanism of APP action in vivo. APP knock-out
mice are viable and show developmental neuronal deficits, namely
cortical migration and agenesis of the corpus callosum, at variable
penetrance depending on genetic background [13–15]. In
contrast, another in vivo report, based mainly on gain of function
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and RNA interference experiments, suggests that APP may be
required for developmental axonal degeneration [16], although it
is unclear whether APP knock-out mice show these phenotypes.
Finally, initial findings proposed an axonal transport function for
APP [17] but later studies strongly questioned the presence of
these defects in APP knock-out mice [18].
Mechanistically, there is also disagreement on whether APP acts
cell autonomously or non autonomously. For example, an
extensive network of molecular interactions has been described
for the intracellular domain of APP [19], yet a knock-in of APP
lacking the intracellular domain appears to rescue physiological
and learning deficits reported in APP knock-out mice, suggesting
that the intracellular domain is dispensable [20]. Because current
models based on Amyloid toxicity do not provide a complete
explanation for the onset of neuronal dysfunction in AD, it has
long been argued that greater attention needs to shift towards
understanding the normal physiological function of APP in order
to assess its potential contribution to AD pathology [21,22].
Therefore, a mechanistic understanding of the in vivo physiolog-
ical function of APP proteins is of paramount importance. To
elucidate the function and mechanism of action of APP proteins in
vivo, we first investigated Drosophila APPL, the APP homologue in
the fruit fly, as a model system. We show that APPL is a novel
neuronal-specific modulator of the PCP pathway required for the
robustness of axonal outgrowth during the development of the
Mushroom Bodies (MB), a Drosophila center for learning and
memory. APPL carries out this function through facilitating the
PCP-specific phosphorylation of the Wnt adaptor protein Dishev-
elled (Dsh/Dvl) by the Abelson kinase (Abl). Furthermore, we
show that APPL is part of the membrane complex formed by Wnt-
PCP core proteins. Finally, biochemical and cell biological
analyses show that human APP immunoprecipitates mammalian
PCP proteins and that APP proteins are necessary for Dvl
phosphorylation in response to the PCP ligand Wnt5a. Therefore,
the APP proteins represent a novel and conserved family of
neuronal modulators of Wnt-PCP signaling required for the
robustness of brain wiring during development.
Results
APPL Is a Robustness Factor Required Cell-Autonomously
for MB b-Lobe Development
Drosophila APPL is a neuronal-specific protein expressed in most,
if not all, neurons throughout development and adult life. In
particular, APPL is highly expressed in the developing Drosophila
MB, especially the so-called ab neurons (Figure 1A–D). Flies null
for Appl (henceforth Appl2/2) are viable, fertile, and reported to
show no gross structural defects in the brain [8]. While a
requirement for APPL in learning and memory specifically in
adult flies has been shown [23], the function of its pan-neuronal
expression throughout development remains unknown, as does the
in vivo mechanism of its action(s).
We began addressing the function of APPL in neuronal
development by carefully examining the development of the
Drosophila MB in Appl2/2 mutant flies. The MB derives from two
groups of four neuroblasts, one in each hemisphere, that
sequentially generate three subsets of neurons: the c-, a9b9 and
ab neurons, where APPL is highly expressed. Each ab neuron
projects an axon that branches into a dorsal ‘‘a branch’’ and a
medial ‘‘b branch.’’ The fascicles generated by each of these
branches are referred to as the a lobe and b lobe. The a and b
lobes can be easily visualized using the anti-FascilinII (FasII)
antibody. The lobes were present and morphologically normal in
97 adult control animals (Figure 1E) examined. In contrast, 26%
of Appl2/2 brains examined (n=101) showed axonal defects
(Figure S1). Specifically, 14% of the brains show a-lobe loss
(Figure 1F), whereas 12% of the brains show b-lobe loss
(Figure 1G). These defects are developmental in origin as they
can be observed during ab lobe formation at 48 h of pupal
development (Figure 1H–J). To ascertain whether APPL acts cell
autonomously to regulate MB axonal outgrowth, we generated
GFP-marked single Appl2/2 cell clones using the MARCM
technique [24]. While none of the control clones showed any
defects (Figure 2A), 10% of the mutant clones showed lack of b-
lobe growth (Figures 2B and S2A), similar to the penetrance
observed in null mutant brains. However, none of the mutant
clones showed loss of a-lobe growth. Taken together, these data
indicate that APPL is required for normal MB axonal outgrowth
and that it is required cell-autonomously for the growth of the b-
lobe and non-cell autonomously for the growth of a lobe. To verify
the specificity of the Appl2/2 phenotype, we rescued the defects by
restoring APPL expression in ab neurons. Expression of full-length
membrane-bound APPL, but not a secreted form or a form
lacking the intracellular domain (ApplDC), strongly suppresses the
b-lobe loss phenotype (Figures 2C–H and S2B). These results
indicate that APPL is required as a full-length, membrane-tethered
protein and that the intracellular signaling downstream of APPL is
necessary for normal b-lobe outgrowth. Interestingly, secreted
APPL strongly reduces the loss of the a lobe (Figure S2C and
S2D), confirming that APPL acts non-autonomously in a-lobe
outgrowth. All together, the results suggest that APPL is a
robustness factor for an unknown axon growth signal whereby
Appl2/2 ab neurons are at a phenotypic threshold that causes
them to fail to grow in approximately 26% of the cases.
Abelson Kinase Is a Downstream Effector of APPL
Required for MB Axon Outgrowth
To unravel the mechanism by which APPL supports MB axon
outgrowth, we chose to focus on the cell-autonomous function of
APPL in the b lobe. A previous study using APPL gain of function
indicates that APPL overexpression induces axonal outgrowth that
is dependent on Abl kinase activity [25]. We asked whether Abl
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kinase also acts downstream of APPL during MB b-lobe growth.
First, we tested if APPL genetically interacts with Abl. To this end
we analyzed the adult MB morphology of Appl2/2; Abl2/+ flies.
Loss of one copy of Abelson causes a dramatic increase (up to
51%) in complete (41%) or partial (10%) b-lobe loss, compared to
Appl2/2 alone (Figure 3A, 3B and 3E, 3F). As controls we
analyzed the siblings heterozygous for both Appl and Abl (Appl2/+;
Abl2/+) and observed no phenotypes (Figure 3F). Similarly to
Appl2/2 mutants alone, the phenotypes arise at early develop-
mental stages (Figure S3A). To further confirm that Abl is the
downstream mediator of APPL signaling during b-lobe growth, we
tested if overexpression of Abl specifically in MB ab neurons
rescues the Appl null phenotype. We find that wild-type Abl, but
not a Kinase Dead (Abl-KD) form of Abl, rescues the Appl null
phenotype (Figure 3C–F) to the same extent as MB ab expression
of APPL itself (Figure S2B). Taken together these data indicate
that Abl is the effector of APPL required for the b-lobe growth.
Next, we further characterized the downstream pathway involved.
APPL Is a Novel Neuronal-Specific Modulator of PCP
Signaling
It has been recently shown that Abl phosphorylates Disheveled
(Dsh), a core intracellular component of the Wnt pathway, on the
Tyrosine 473. This modification is required for the efficient
activation of the PCP signaling pathway in epithelial cells [26].
Interestingly, in the nervous system the Wnt-PCP pathway is
required for robust axonal outgrowth both in Drosophila [27] and
mouse [28,29]. More recently, several PCP pathway components,
like the Wnt receptor Frizzled (Fz), Flamingo (Fmi), Strabismus
(Stbm or Vang), and Dsh, have been shown to play a role in the
correct targeting and bifurcation of MB axons [4,30,31]. Indeed,
we observe that flies harboring a PCP-specific mutation in Dsh
(dsh1) [32] show the same MB developmental defects observed in
Appl2/2 flies (Figure 4A).
Together, these observations prompted us to speculate that
APPL acts to facilitate Wnt-PCP pathway activation during MB
development by mediating Dsh phosphorylation by Abl. To verify
this hypothesis we tested if the phosphorylation of Dsh on Y473 is
required for MB development. We analyzed dsh1 flies harboring
one of two genomic rescue constructs: a wild-type construct (dsh-
DshGFP-wt) or a Tyrosine 473 phospho-mutant construct (dsh-
DshGFP-Y473F). Whereas the restoration of wild-type Dsh fully
rescues the dsh1 MB phenotype (Figures 4B and S4A), DshY473F
completely fails to do so (Figures 4C and S4A). To exclude that
DshY473F failure to rescue the phenotype is due to a perturbation
in the expression pattern resulting from the point mutation, we
performed anti-GFP staining on adult brains of both transgenic
lines. As shown in Figure 4D and 4E, both wild type and mutant
Dsh are expressed in the MB lobes. These results clearly indicate
that Abl phosphorylation of Dsh on Tyrosine 473 and the
subsequent activation of Wnt-PCP signaling are required for the
b-lobe growth.
Collectively, the data suggest the exciting possibility that APPL
may be a neuronal-specific component of the Wnt-PCP pathway.
To address this issue, we first asked if APPL interacts genetically
with core members of the Wnt-PCP pathway like the classical
Wnt-PCP receptor Fz and the canonical Wnt-PCP protein Van
Gogh/Strabismus (Vang/Stbm). We first analyzed the b-lobe of
Appl2/2; Fz2/+ flies. Reduction of Fz in the APPL null
background increases the frequency of the b lobe loss up to
21%, whereas no phenotype is observed in control siblings
(Figures 5B, E and S5A). This interaction is specific to the MB
because expression of a dominant negative form of Fz (Fz-DN) in
Appl2/2 ab neurons yields similar results (Figures 5C, 5E and
S5A). In both experiments described, the increase in b-lobe loss is
relatively mild compared to the dramatic increase in b-lobe loss
due to APPL-Abl epistasis for example, suggesting that APPL and
Fz may act together for Wnt-PCP activation. To clarify this, we
tested if inhibition of Fz alone is sufficient to induce the b
phenotype. Overexpression of Fz-DN in ab neurons of wild-type
flies did not cause any morphological defects (Figure S5A and
S5B). These data were further confirmed by the analysis of Fz
mutant ab clones of different sizes. None of the analyzed MB
clones showed morphologically aberrant axons (Figure S5C). To
rule out compensation by Fz2, we examined Fz2 expression in the
brain and found that it is not detectable in MB (unpublished data).
Furthermore, MARCM clones null for Fz2 alone or Fz and Fz2
together show no aberrant morphology (Figure S5D and S5E).
Therefore, APPL function is a critical determinant of the role of
PCP in the outgrowth of MB b axons. To further ascertain the
interaction with the Wnt-PCP pathway, we analyzed if APPL
interacts with the Wnt-PCP four-pass transmembrane protein
Vang/Stbm. Reduction of Van Gogh in the Appl null background
(Appl2/2;vang2/+) increases the frequency of the b-lobe loss
phenotype to 33% (Figures 5D,E and S5A), whereas no phenotype
is observed in control siblings. APPL is also expressed in the
developing fly retina (Figure S5F), where the PCP pathway
regulates the polarity of photoreceptor cells. However, we did not
observe defects in photoreceptor polarity (Figure S5G–I), suggest-
ing that the role of APPL in Wnt-PCP signaling is specific to
axonal outgrowth. Together, the data above identify APPL as the
first neuronal-specific modulator of the Wnt-PCP pathway’s role
in axonal outgrowth. Next, we analyzed if the expression pattern
of Vang and APPL overlaps during MB development. For this
purpose, we used a line that expresses a YFP tagged form of Vang
under the control of the Actin promoter. As shown in Figure 5F,
during the development of the b lobe both APPL and Vang are
expressed at a high level in the growing axons. Interestingly, in
adult stage, APPL expression is reduced in the rest of the brain and
enriched in the ab neurons while Vang levels are strongly reduced
Figure 1. APPL is a robustness factor required for Mushroom Bodies development. (A–D) Developmental APPL expression in MB. Immuno-
fluorescence analysis using anti-APP-Cterm (A–D in magenta) and anti-FasII (A9–D9 in green) antibodies. The A-–D- panels show the merge of the
FasII and GFP channel for the indicated samples. APPL is expressed at high levels in the developing brain and is enriched along MB axons both during
development and in adult stages. (A, B) 48 h APF MB lobes. The images are single confocal stacks; zoom shows 636magnification of the boxed area
(scale bar, 50 mm in A, 25 mm in B). (C) Adult MB axons. The images are single confocal stacks (scale bar, 50 mm). (D) Zoom shows 636magnification
of the boxed area in panel C. The images are z-projections of two confocal image stacks (step size, 0.6 mm; scale bar, 25 mm). (E–G) Adult MB lobes
labeled with FascilinII antibody (FasII). All images are z-projections of confocal image stacks (scale bar, 50 mm). (E) Morphologically normal a/b
neurons in control adult brain. (F–G) Structure of a/b neurons in Appldw* null mutant adult brains. In the absence of APPL, MB lobes show an aberrant
pattern of growth in 26% of the analyzed sample (n=101). In particular, in 14% of the cases (F), the a lobe fails to project towards the dorsal side of
the brains (as indicated by the arrow), whereas in 12% of the cases (G), the b lobe fails to project towards the midline (as indicated by the arrow). (H)
Morphologically normal a/b neurons of a 48APF Canton S brain. (I–J) Morphologically aberrant a/b neurons of an Appld w*48APF brain. The a- (I) and
b-lobe (J) loss observed in the adult brain is already present at 48 APF, thus suggesting that is not due to degeneration but rather to failure in axon
growth.
doi:10.1371/journal.pbio.1001562.g001
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Figure 2. APPL is cell-autonomously required for b-lobe development. (A–B) Z-projections of confocal image stacks of GFP-labeled clones.
Recombination was induced at 0–24 h APF. Immunofluorescence analysis of adult MBs using anti-GFP (green) and anti-FasII (A9, B9 in magenta)
antibodies (scale bar, 50 mm). The A0 and B0 panels show the merge of the FasII and GFP channel for the indicated samples. (A) Morphologically
normal a/b neurons in single-cell control clones obtained by crossing FRT19A; ry506 flies with FRT19A,tub-Gal80,hsFLP/FM7;UAS-CD8-GFP/CyO;OK107
(n=41 clones). (B) Appld single-cell clones. Clones were obtained by crossing Appld FRT19A/FM7 with FRT19A, tub-Gal80, hsFLP/FM7; UAS-CD8-GFP/
CyO; OK107. The cell-autonomous loss of APPL leads to b-lobe loss in 10% of the clones analyzed as indicated by the arrow (n=44 clones). (C–G)
Adult MB lobes labeled with FasII antibody. All the images are z-projections of confocal image stacks (scale bar, 50 mm). (C) Morphologically normal a/
b neurons in a control adult brain. (D) Morphologically aberrant ab neurons in Appldw*/Y;L/+;P247Gal4 analyzed as a control for the rescue
experiment (n= 47). In 13% of the brains the b axons failed to grow towards the midline. (E) Morphologically normal ab neurons in Appldw*/Y;UAS-
Appl/+;P247Gal4 adult brains. The re-introduction of full-length APPL in MBs during development is sufficient to rescue the b-lobe defect. Only 2% of
the samples show a phenotype; p value= 0.03467 calculated with G-test (n= 50). (F) Morphologically aberrant ab neurons in Appldw*/Y;UAS-sAppl/
+;P247Gal4. The re-introduction of a secreted form of APPL fails to rescue the b-lobe defect, where 12% of the analyzed brains showed phenotype. p
value = 0.9831 calculated with G-test (n= 50). (G) Morphologically aberrant ab neurons in Appldw*/Y;UAS-ApplDC/+;P247Gal4. The re-introduction of a
form of APPL lacking the C-terminal domain fails to rescue the b-lobe defect, where 11% of the analyzed brains showed phenotype (n= 54); p
value = 0.8863 calculated with G-test. (H) The graph shows the penetrance of the b-lobe loss in the rescue flies normalized against the penetrance of
the phenotype in the Appldw* background. * Indicates a p value,0.05 calculated with G-test.
doi:10.1371/journal.pbio.1001562.g002
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in these axons (Figure 5G). Moreover, in the developing fly retina,
APPL and Vang do not colocalize and are found in juxtaposed
domains (Figure S5L). Taken together these results suggest that
both APPL and Vang are present in developing ab axons where
their genetic interaction is required for the correct development of
the b axons. On the contrary, the two proteins are expressed in
different compartments in the fly retina where APPL function is
not required for PCP activity.
Finally, to confirm that PCP signaling is indeed positively
modulated by APPL and that the activation of the signaling is
required for the b-lobe growth, we performed rescue experiments
with Dsh. As shown in Figure 5F, overexpression of Dsh in the
Appl2/2 background strongly reduces (7%) the b-lobe loss but does
not fully rescue the phenotype. This result indicates that the
phosphorylation of Dsh by Abelson is the limiting step in the
activation of PCP signaling; increasing the amount of Dsh present
in the neurons improves the phenotype, but probably the
endogenous Abelson is not sufficient to phosphorylate the whole
pool of Dsh. To overcome this problem we decided to enhance the
activation of PCP signaling by overexpressing Wnt5 in the Appl2/
2 background. Interestingly, overexpression of Wnt5 significantly
rescues the b-lobe loss (Figure 5H), indicating that the PCP
signaling activation is required for the development of the b lobe
and is reduced in absence of APPL.
APP Is Required for Dvl2 Phosphorylation in Response to
Wnt5 and Forms Complexes with PCP Core Proteins
The previously described results raise two important questions.
First, is the interaction between APPL and the Wnt-PCP pathway
conserved in mammalian APP proteins? Second, if so, do the
genetic interactions observed in Drosophila reflect a biochemical
association of APPL/APP with the Wnt-PCP receptors? To
address these issues, we first investigated if mouse APP proteins
mediate the phosphorylation of mouse Disheveled (Dvl) in
response to the Wnt-PCP ligand Wnt5a. To this end, we analyzed
Dvl phosphorylation in response to Wnt5a treatment in wild-type
versus APP/APLP2 double knock-out mouse embryonic fibroblast
(dKO MEFs). In WT MEFs, Dvl2 phosphorylation increases
dramatically upon treatment with Wnt5a. In contrast, Dvl2 in
dKO MEFs completely fails to respond to Wnt5a treatment
(Figure 6A). The effect on the activation of Dvl2 is a direct
consequence of APP loss because upon reintroduction of APP
cDNA Dvl2 phosphorylation is restored (Figure 6A). Next, we
tested if APPL and APP interacts with core Wnt-PCP receptor
proteins. In particular, we performed co-immunoprecipitation
(Co-IP) analyses of tagged proteins expressed in HEK-293T cells.
As shown in Figures 6B and S6B, APPL immunoprecipitates Vang
when the two proteins are co-expressed in the same cells. Drosophila
APPL immunoprecipitates human Van Gogh 2 (Vangl2)
Figure 3. Abelson kinase is a downstream effector of APPL required for MB axons outgrowth. (A–B) Loss of b lobes in Appldw*/Y;Abl4/+
adult brains. (A) In 40% of the flies that have lost one copy of Abl in the Appl2/2 background, no axons grow toward the midline (indicated by the
arrow), whereas in 10% of the cases (B) only few axons project normally (n= 29); p value= 1.29E-02 calculated with G-test. (C) Morphologically normal
ab neurons in Appldw*/Y;UAS-Abl/+;P247Gal4 adult brains. Overexpression of Abl in the MB rescues the b-lobe loss in the Appl2/2 background. Only
2% of the analyzed samples show b-lobe loss (n= 46); p value= 0.03192 calculated with G-test. (D) Morphologically aberrant ab neurons in Appldw*/
Y;UAS-Abl-KD/+;P247Gal4 adult brains. Overexpression of a Kinase dead form of Abl fails to rescue the b-lobe loss in the Appl2/2 background. Thirteen
percent of the analyzed brains showed b-lobe loss as indicated by the arrow (n= 31). (E) The graph shows the penetrance of b-lobe loss in the Abl
rescue flies and in the flies heterozygous for Abl, normalized against the penetrance observed in the Appldw* background. (F) The table lists the
number of brains analyzed in the rescue experiments. * Indicates a p value,0.05 calculated with G-test; ** indicates a p value,0.001 calculated with
G-test.
doi:10.1371/journal.pbio.1001562.g003
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(Figures 6C and S6C). Importantly, this multiprotein complex can
only be detected when the proteins are expressed in the same cells,
but not when lysates from separately expressing cells are mixed
(Figure S6E). This observation also accounts for the absence of
rescue observed when a form of APPL lacking the C terminal is
expressed in the Appl2/2 animals (Figure 2H). Similarly, the
membrane tethered C-terminus of human APP (APP-C99)
immunoprecipitates Vangl2 (Figures 6D and S6D). Moreover,
we tested if APPL also immunoprecipitates other PCP receptors
like Fz. As shown in Figures 6E and S6F, APPL immunoprecip-
itates Fz, suggesting that the core PCP proteins and APPL might
form a multiprotein complex on the membrane, responsible for
the efficient activation of the pathway. Similarly, the membrane-
tethered C-terminus of human APP (APP-C99) immunoprecipi-
tates human Fzd5 (Figure 6F).
Discussion
AD is a neurodegenerative disorder characterized by progres-
sive loss of neurons in specific regions of the brain that correlates
with progressive impairment of higher cognitive functions. A
growing body of evidence identifies the APP and its metabolite the
Ab peptide as main players in the pathogenesis of AD. In
particular, the accumulation of Ab peptides in the brain seems to
be the trigger of the pathological cascade that eventually results in
neuronal loss and degeneration [33]. Despite efforts to character-
ize the molecular mechanisms underlying Ab’s toxic function, it is
Figure 4. Dsh phosphorylation is required for MB b-lobe development. Structure of ab neurons labeled with FasII antibody. All the images
are z-projections of confocal image stacks (scale bar, 50 mm). (A) Morphologically aberrant ab neurons in dsh1 adult brains. Flies homozygous for a
PCP specific allele of dsh (dsh1) show a phenotype comparable to Appl2/2 mutants but with increased penetrance of b-lobe loss as indicated by the
arrow (30%; n= 36). (B) Morphologically normal ab neurons in dsh1/Y;dsh-DshGFP-wt/+ adult brains. Reintroduction of wild-type Dsh in the dsh1
mutant background completely rescues b-lobe loss with no brains showing defects (n= 31). (C) Morphologically aberrant ab neurons in dsh1/Y;;dsh-
DshGFP-Y473F/+ adult brains. Reintroduction of a Tyrosine 473 phospho-mutant form of Dsh in a dsh1 mutant background fails to rescue the b-lobe
loss as indicated by the arrow (n=41). (D–E) Expression pattern of Dsh-GFP in ;dsh-DshGFP-wt/TM6b and of Dsh-Y473F-GFP in ;dsh-DshGFP-Y473F/+.
Immuno-fluorescence analysis of adult brains using anti-GFP (green) and anti-FasII (D9, E9 in magenta) antibodies (scale bar, 50 mm). All images are z-
projections of two confocal sections (0.9 mm steps). The D0 and E0 panels show the merge of the FasII and GFP channel for the indicated samples.
doi:10.1371/journal.pbio.1001562.g004
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Figure 5. APPL interacts with PCP signaling during MB development. (A–D) Structure of ab neurons labeled with the FasII antibody. All the
images are z-projections of confocal image stacks (scale bar, 50 mm). (A) Morphologically normal ab neurons in a control adult brain. (B)
Morphologically aberrant ab neurons in Appldw*/Y;;FzKD/+ adult brains. Loss of one copy of Fz in the Appl2/2 background increases moderately, but
not significantly, the penetrance of b-lobe loss (indicated by the arrow) to 21% (n= 28); p value= 0.2166 calculated with G-test. (C) Morphologically
aberrant a/b neurons in Appld w*/Y;UAS-Fz-DN/+;P247Gal4/+ adult brains. Overexpression of a dominant negative form of Fz in the Appl2/2
background increases moderately, but not significantly, the penetrance of the phenotype to 18% (n=28); p value= 0.4226 calculated with G-test. (D)
Morphologically aberrant ab neurons in Appld w*/Y;Vangstbm-6/+ adult brains. Loss of one copy of Vang in the Appl2/2 background increases the
penetrance of the b-lobe loss up to 33% (n= 21); p value = 0.02304 calculated with G-test. (E) The graph shows the penetrance of b-lobe loss in
genetic interaction experiments, normalized against the penetrance in the Appldw* background. (F, G) APPL and Vang localization during
development in brain of flies Act-Stbm-EYFP expressing an EYPF tagged form of Vang under the control of the Actin promoter. Immuno-fluorescence
analysis using anti-APP-Cterm (F, G in blue), anti-GFP (F9, G9 in green), and anti-FasII (F0, G0 in red) antibodies. The images are single confocal stacks
(scale bar, 25 mm). The F- and G- panels show the merge of the FasII and GFP channel for the indicated samples. (F) At 48 h APF, Vang is broadly
expressed along the MB b axons, where also APPL is expressed as indicated by the arrow. (G) At adult stage, the level of Vang detectable in the b
axons is strongly reduced compared to the previously analyzed time point, while APPL is enriched in the MB neurons (as indicated by the arrow). (H)
The graph shows the penetrance of the b-lobe loss in the Appldw* flies overexpressing Dsh or Wnt5 (p value equal to 0.1287 and 0.0006692,
respectively). Activation of Wnt-PCP signaling upon Wnt5 signaling rescues the b-lobe phenotype. ** Indicates a p value,0.001 calculated with G-
test.
doi:10.1371/journal.pbio.1001562.g005
Figure 6. APP is required for the proper response to Wnt5 and forms complexes with PCP core proteins. (A) Analysis of the
responsiveness of wt MEFs and MEFs lacking all the APP isoforms to Wnt5 treatment. MEFs were treated for 2 h with rmWnt5a and subsequently
analyzed by Western blot. After the Wnt5 treatment, Dvl2 is phosphorylated and this modification is indicated by a shift of the band detected by Dvl2
Ab. KO MEFs respond less efficiently to Wnt5. Re-introduction of hAPP rescues the responsiveness to Wnt5. The graph shows a quantification of the
ratio between phospho-Dvl2 and Dvl2 in the analyzed samples. * Indicates a p value,0.05 calculated with one-way ANOVA plus Tukey’s multiple
comparison test. (B) Co-immunoprecipitation (Co-IP) of Appl-FLAG and Vang-Myc. The tagged proteins were co-expressed in HEK293T cells and
immunoprecipitated with anti-FLAG antibody. Vang-Myc can be precipitated upon IP of Appl-FLAG. (C) Co-IP of Appl-FLAG and human Vangl2-HA.
Human Vangl2-HA can be precipitated upon IP of Appl-FLAG. (D) Co-IP of human APP (C99)-FLAG and human Vangl2-HA. Human Vangl2-HA can be
precipitated upon IP of APP (C99)-FLAG, indicating that interaction with PCP proteins is a conserved feature of APP proteins. (E) Co-IP of Appl-FLAG
and dFz-GFP. Drosophila Fz can be precipitated upon IP of Appl-FLAG. (F) Co-IP of human APP (C99)-FLAG and human V5-Fzd5. V5-Fzd5 can be
precipitated upon IP of APP (C99)-FLAG.
doi:10.1371/journal.pbio.1001562.g006
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still not clear what triggers the accumulation of the peptide and how
this is correlated with the pathogenesis of the disease and the
dementia. In fact, most of the work done to unveil the pathogenesis
of the disease has focused on the analysis of Ab-peptide and the
search for its receptors and downstream effectors. Even though the
numerous in vitro studies performed in cell culture identified several
molecules that interact with Ab peptide, the in vivo biological
relevance of these interactions remains to be clarified. The amyloid
cascade hypothesis has also dominated the search for AD treatments,
but the promising molecular candidates developed to modulate the
Ab peptide and reached clinical trials failed [34,35]. Finally, over the
last few years many studies indicated that there is no linear
correlation between the accumulation of the peptide and the
cognitive decline, leading to a revision of the amyloidogenic
hypothesis. Taken together, these observations suggest that the
accumulation of the peptide is not the only cause of the pathology
and that other factors are involved. Interestingly, under physiological
conditions APP is mainly found in its uncleaved or a-cleaved form,
suggesting that the shift towards amyloidogenic processing not only
increases the production of Ab peptide but also depletes the pool of
APP that undergoes non-amyloidogenic processing, with hitherto
unknown consequences. It is therefore of paramount importance to
understand the physiological role of APP and how perturbing this
role could contribute to the pathogenesis of the disease. An
important contribution to the study of the function of a protein
comes from the analysis of the knock-out (KO) animals. In the case of
APP, several KOmodels have been generated and analyzed in detail
both from the morphological and behavioral point of view [13,36–
38]. Despite these efforts, the normal physiological function of APP
in vivo in the nervous system remains largely elusive and highly
controversial. This is due to the lack of consensus over the neuronal
phenotypes in null mutant animals and the mechanism of action in
vivo. The data collected by different labs confirmed the involvement
of APPs in development and function of the nervous system, but
these studies do not provide an in-depth analysis of the development
of the brain during the pre-natal stages or the molecular mechanism
underlying APPs’ putative functions. We therefore took advantage of
Drosophila melanogaster to further analyze the consequence of loss of
APP Like (APPL) during brain development.
In the present study we demonstrate that APPL is involved in
brain development of Drosophila melanogaster, particularly in the
Mushroom Body (MB) neurons. We show that APPL is required
for the development of ab neurons. In Appl2/2 flies, MB neurons
fail to project the a lobe in 14% of the cases and the b-lobe in 12%
of the cases (Figure 1). Further analysis of the phenotype reveals
that APPL is required cell-autonomously for the development of
the b lobe and non-cell autonomously for the development of the a
lobe. In fact, single cell Appl2/2 clones display only b-lobe loss and
no a loss. The re-introduction of a full-length, membrane-tethered
form of APPL, but not a soluble form, rescues b-lobe loss
(Figure 2). This is of particular interest because it confirms that,
similar to mammalian APPs, the physiological role of APPL is
mediated both by its full-length form, required in the neurons to
achieve the correct b-lobe pattern, and by its soluble form (sAPPL)
that regulates the extension of the a lobe. Moreover, the rescue
data indicate that, at least in this context, the function of sAPPL is
mediated not by homo-dimerization with the full-length form but
by some other receptor, hitherto unknown. Further experiments
are required to clarify the sAPPL non-cell autonomous effect, but
we hypothesize that it might be involved in modulating signaling
mediated by the cells that surround the MB axons. Taken
together, the analysis of the Appl2/2 animals confirmed the
important role of APPs during brain development but reinforced
the idea that the phenotypes are present with incomplete
penetrance and might be subtle. It would therefore be of interest
to analyze the phenotype of the KO mice in greater detail and, in
particular, to better characterize the APP’s downstream pathway
leading to these defects.
Moreover, the results described clearly support a model of
APPL as a novel, neuronal-specific positive modulator of the Wnt-
PCP pathway (Figure 4). The PCP pathway was initially described
because of its role in tissue polarity establishment and, in
particular, of its regulation of cell orientation in plane of an
epithelium. Among the different processes regulated by PCP
signaling, we are interested in axon growth and guidance. It has
been described that mice null for Fzd3/Ceslr32/2 genes show
severe defects in several major axon tracts like thalamocortical,
corticothalamic, and nigrostriatal tracts, defects of the anterior
commissure, and similarly to APP KO mice, the variable loss of
the corpus callosum [5,39].
The molecular mechanism underlying the function of PCP-
signaling in regulating tissue polarity has been broadly studied.
The current model suggests that, upon polarized expression of the
different core proteins, Dsh is recruited to the membrane via Fz
and leads to the activation of a cascade of small GTPases finally
resulting in cytoskeleton rearrangements. In the case of regulation
of axon growth and guidance, it is less clear how the signaling is
regulated and transmitted to the cytoskeleton. A recent publication
suggested that during axon growth the transmembrane PCP
receptor-like Vang and Fzd are localized at the growth cone area
on the tip of the fillopodia, thus suggesting that in this context the
asymmetric localization is not needed [28].
Furthermore, Dsh needs to relocalize from the cytoplasm to
the membrane to ensure the proper activation of PCP signaling,
and this is dependent on its phosphorylation status. Singh and
colleagues showed that Abelson is one kinase responsible for this
modification, but the receptor upstream of the kinase was not
identified [26]. Based on the evidence we generated, we propose
that APPL is a novel regulator of Wnt-PCP pathway involved in
axon growth and guidance (Figure 7). This is of interest because
while the PCP core proteins are ubiquitously expressed, APPL is
restricted to the nervous system, suggesting that it could be the
first described tissue-specific modulator of the pathway.
Mechanistically, we propose that APPL-Abl complex modulates
Dsh via dual protein-protein interactions. First, Abl might have an
intrinsic affinity for its substrate Dsh [26]. Secondly, this interaction
is strengthened or stabilized by the inclusion of APPL in a PCP
receptor complex. This dual affinity complex leads to increased PCP
signaling efficiency at the developing growth cone. Both biochemical
and physiological data show that this function is highly conserved in
mammalian APP, suggesting that it may play a similar role in the
mammalian brain. The canonical-Wnt signaling pathway has
already been connected to AD pathogenesis because of its link to
the tau-kinase GSK-3b. Interestingly, no clear link between theWnt-
PCP pathway and this neurodegenerative disorder has been made.
Previous reports [27,28] show that, in flies and mice, Jun N-terminal
Kinase (JNK) is the final effector of PCP in axon outgrowth and JNK
was shown to be required for the effect of APP overexpression in the
fly [25,40]. Interestingly, JNK signaling has also been linked to the
neuronal loss observed in AD [41]. It is therefore worth investigating
whether the physiological function of APP as a neuronal PCP
modulator explains the JNK-AD connection.
Materials and Methods
Fly Stocks
Drosophila stocks used include Appld w*, Appld,FRT19A w*,
elavC155,hsFLP,w*;UAS-mCD8::GFP.,UAS-lacZ/CyO;tubP-GAL80,
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FRT2A/TM6,Tb,Hu, hsFlp,UAS-CD8-GFP;;FRT2A,tubGal80/
TM3;OK107, hsFlp, UAS-CD8-GFP; FRT2A, tubGal80/
TM3;OK107, Flp122; sp/CyO;Fz p21,ri,FRT2A/TM2,
fz2C1ri,FRT2A/TM3,Sb, yw,hsflip;Fz1H51Fz2C1riFRT2A/TM2,
UAS-Fz-DN/CyO;P247Gal4/TM6c, UAS-Abl-KD/CyO;P247-
Gal. Abl4 kar1 red1 e1/TM6B, Tb1, w*;UAS-Abl/CyO;P247, w;
fz [KD]/TM3,Sb, Vangstbm-6, w;201Y,UAS-GFP, FRT19A;ry50,
FRT19A,tub-Gal80,hsFLP/FM7;UAS-CD8-GFP/CyO;OK107,
UAS-Appl/CyO;P247Gal4, UAS-sAppl/Cyo;P247Gal4, w1,
dsh:1, dsh.Dsh-GFP (J7)/TM6. dshV26,dsh.Dsh-GFP;
dsh.Dsh-GFP Y473F, and Act-stbm-EYFP/TM3.
Accession Numbers/ID Numbers
APPL (FBgn0000108), fz (FBgn0001085), fz2 (FBgn0016797),
Fzd5 (NP_003459.2), dsh (FBgn0000499), dvl1 (AAB65242.1),
dvl2 (AAB65243.1), Vang (FBgn0015838), Vagl2 (NP_065068.1),
and Abl (FBgn0000017).
Immunochemistry
Larval, pupal, or adult brains were dissected in phosphate
buffered saline (PBS) and fixed in 3.7% formaldehyde in PBT
(PBS+ Triton 6100 0.1%) for 15 min. The samples were
subsequently rinsed three times in PBT and blocked in PAX-
DG for 1 h. Following these steps, the brains were incubated with
the primary antibody diluted in PAX-DG overnight at 4uC. This
incubation was followed by three washes with PBT and a
subsequent incubation with the appropriate fluorescent secondary
antibodies for 2 h at RT. After three rinses in PBT, the brains
were put in 50% Glycerol diluted in PBS and then mounted in
Vectashield (Vector Labs) mounting medium. The following
antibodies were used: rabbit anti-GFP (Invitrogen, 1:1,000),
mouse anti-FasII (Hybridoma Bank, 1:50), rabbit anti-APP-C-
term (kind gift of Bart de Strooper lab, 1:5,000), and anti-
Phalloidin TRITC (1:1,000).
Microscopy and Image Analysis
The mounted brains were imaged either on a LEICA DM 6000
CS microscope coupled to a LEICA CTR 6500 confocal system or
on a Nikon A1-R confocal (Nikon) mounted on a Nikon Ti-2000
inverted microscope (Nikon) and equipped with 405, 488, 561,
and 639 nm lasers from Melles Griot. The pictures were then
processed using ImageJ and Adobe Photoshop.
MARCM Procedure
Crosses were set up at 25uC and transferred every day. We
transferred 0 to 24 pupae in a fresh vial, and they were heath
shocked for 459 at 37uC and shifted back at 25uC until eclosion.
The morphology of the MB clones was analyzed in flies 0–7 d old.
Cell Culture and Treatments
WT MEFs, APP/APLP2 double KO MEFs, APP/APLP2
double KO+hAPP, and HEK-293T cells were propagated in
DMEM, 10% FCS, 2 mM L-glutamine, 50 units/ml penicillin, 50
units/ml streptomycin. MEFs (200,000 cells per well) were seeded
in 24-well plates for biochemical analyses. MEFs were treated 2 d
after seeding with rmWnt5a (R&D Systems) for 2 h. Cells were
harvested for immunoblotting by direct lysis in 16Laemmli buffer
followed by boiling at 95uC for 5 min. Control stimulations were
done with 0.1% BSA in PBS.
Gel Electrophoresis and Western Blots
Protein from total cell lysates/samples was resolved in 10%
polyacrylamide gels (SDS-PAGE) under denaturing conditions
and then transferred to nitrocellulose membranes. The blots were
probed using polyclonal anti-FLAG M2 (F1804, Sigma-Aldrich
1:1,000), monoclonal anti-Myc (M4439,Sigma-Aldrich 1:1,000),
anti-Dvl1 (sc-8025, Santa Cruz Biotechnologies, 1:1,000), anti-
Dvl2 (#3224, Cell Signaling Technologies, 1:1,000), anti-V5
(R960-25, Invitrogen, 1:1,000), anti-HA (HA.11, MMS-101R,
Covance, 1:2,000), and anti-beta-actin (sc-1615, Santa Cruz
Biotechnology, 1:2,000). Bands were visualized using anti-IgG
HRP-conjugated secondary antibodies, and the ECL Western
Blotting Detection System (GE Healthcare, UK).
Co-Immunoprecipitation
For the Co-IP of Drosophila proteins, pCDNA3-APPL-FLAG
and pCDNA3-Vang-Myc were transiently transfected in
HEK293T cells (4.56106 cells per 10 cm dish) using Fugene
HD (Roche). After 3 d, cells were collected in Lysis Buffer
(150 mM NaCl, 50 mM Tris/HCl pH 7.5, 10% glycerol, 0.4%
Nonidet P-40) and cleared with Dynabeads M-270 epoxy
(Invitrogen) for 459 at 4uC. After the clearing, lysates (half volume)
were incubated with anti-FLAG covalently conjugated to
Dynabeads M-270 (pre-saturated with BSA) for 1 h at 4uC. Beads
were then washed, and bound proteins were resuspended in 66
Laemmli and subjected to SDS-PAGE followed by Western blot
analysis. For the Co-IP of Drosophila and human proteins,
HEK293 cells grown at 50% confluency on 10-cm plates were
transfected with 6 mg of each plasmid. After 2 d, cells were lysed
for 15 min in 1 ml of lysis buffer ([0 mM Tris buffer pH 7.4,
150 mM NaCl, 1 mM EDTA, 0.5% NP40 supplemented with
1 mM DTT and protease inhibitor cocktail (Roche, cat.
no. 11836145001)]. Lysates were centrifuged at 13,2006 g for
20 min at 4uC, supernatants were collected, and 0.4 ml of the
supernatant was incubated with 1 mg of indicated immunoprecip-
itating antibody for 1 h at 4uC. Immunoprecipitates were collected
on Protein G sepharose beads by overnight rotation, washed four
times with lysis buffer, resuspended in 26Laemmli sample buffer,
Figure 7. APPL is a novel modulator of Wnt-PCP signaling
required for axon guidance. Schematic representation of the
proposed model. APPL is a novel regulator of Wnt-PCP pathway. In
the presence of Wnt signaling, Fz binds Dsh, which needs to be
phosphorylated by Abelson kinase to correctly relocalize to the
membrane. We propose that Appl is part of the membrane complex
formed by the core PCP proteins Fz1 and Vang. In turn, Appl recruits
Abelson kinase to the complex and positively modulates Dsh
phosphorylation. The subsequent activation of the signaling is required
for MB b-axon growth.
doi:10.1371/journal.pbio.1001562.g007
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and subjected to SDS-PAGE followed by Western blot analysis.
The antibodies used for immunoprecipitation include FLAG M2
(F1804 Sigma-Aldrich), anti-HA (ab9110; Abcam), anti-Myc
(M4439, Sigma-Aldrich), and anti-V5 (R960-25, Invitrogen).
Supporting Information
Figure S1 Appl is required during the development of
Mushroom Bodies for a- and b-lobe growth. (A) The table shows
the number of brains analyzed to characterize the Appl loss of
function phenotype.
(PDF)
Figure S2 APPL is required cell-autonomously for the b-lobe
outgrowth. (A)The table lists the number of brains analyzed in the
MARCM experiments. (B, C) The table lists the number of brains
analyzed in the rescue experiments. (D) Adult MB lobes labeled
with FascilinII II antibody (FasII). The image is a z-projection of
confocal image stacks (scale bar, 50 mm). Morphologically normal
ab neurons in Appldw*/Y;UAS-sAppl/+;P247Gal4 adult brains.
The reintroduction of soluble APPL in MBs during development
strongly reduces the loss of the a lobe.
(PDF)
Figure S3 Abelson kinase is the downstream effector of APPL in
MB development. (A) Structure of a/b neurons of a Appld;;Abl4
48APF brain. The image is a z-projection of confocal image stacks
(scale bar, 50 mm). The MBs are labeled with anti-FasII antibody.
b-lobe loss is detectable already at 48 APF, similarly to what is
observed in the Appl2/2 background.
(PDF)
Figure S4 Dsh phosphorylation is required for MB develop-
ment. (A) The table lists the number of brains analyzed in the dsh
rescue experiments.
(PDF)
Figure S5 Appl interacts with the PCP signaling during MB
development. (A) The table lists the number of brains analyzed in the
PCP genetic interaction experiments. (B) Structure of a/b neurons
labeled with anti-FasII antibody. The image is a z-projection of
confocal image stacks (scale bar, 50 mm).Morphologically normal a/
b neurons in UAS-FzDN/+;P247Gal4/+ adult brains. Expression of
a dominant negative form of fz in the MB is not sufficient to induce
defects. (C–E) Z-projections of confocal image stacks of GFP-labeled
MARCM clones. Immuno-fluorescence analysis of adult MB, using
anti-GFP (green) and anti-FasII (magenta) antibodies. (C) fzp21
mutant clones obtained by crossing elavC155,hsFLP,w*;UAS-
mCD8::GFP,UAS-lacZ/CyO;tubP-GAL80,FRT2A/TM6,Tb,Hu
or hsFlp, UAS-CD8-GFP;; FRT2A, tubGal80/TM3; OK107
with yw Flp122; sp/CyO;fz p21,ri,FRT2A/TM2. fz mutant cells
show normal axon projections, similar to their wild-type
counterparts. (D) fz2C1 mutant clones obtained by crossing
virgins elavC155,hsFLP,w*;UAS-mCD8::GFP.,UAS-lacZ./CyO;
tubP-GAL80,FRT2A/TM6,Tb,Hu or hsFlp, UAS-CD8-GFP;
FRT2A, tubGal80/TM3; OK107 with males fz2C1 ri, FRT2A/
TM3, Sb. Single-cell clones do not show any difference in their
projection pattern compared to wild-type cells. (E) fzH51, fz2C1
double mutant clones obtained by crossing elavC155,hsFLP,
w*;UAS-mCD8::GFP.,UAS-lacZ./CyO;tubP-GAL80,FRT2A/
TM6,Tb,Hu with yw,hsflip; ;fz H51fz2 C1ri FRT2A/TM2. Loss of
both fz and fz2 does not influence b-lobe growth, thus excluding
possible compensatory effects. (F) Appl expression in third instar
larvae eye disc. (G–I) Tangential adult eye sections in areas around
the equator. The colored bars indicate the orientation of the
ommatidia. (H) dsh1 mutant flies show PCP defects and reduction of
symmetric ommatidia. (I) Appl2/2 adult flies show ommatidia
orientation comparable to wild-type flies (G). (J) APPL and Vang
localization during development in brain of flies expressing a EYPF
tagged form of Vang under the control of Actin promoter. Immuno-
fluorescence analysis using anti-APP-Cterm (blue), anti-GFP
(green), and anti-FasII (red) antibodies. The images are single
confocal stacks (scale bar, 15 mm). APPL and Vang are expressed in
mutually exclusive compartments in the developing retina.
(PDF)
Figure S6 APP proteins are found in core PCP complexes. (A)
APP expression levels in wild-type MEFs, KO MEFs, or KO
MEFs stably transfected with APP. Two clones of rescue MEFs
were analyzed. Clone B shows detectable APP levels and was used
for the Wnt5 stimulation assay. (B) Co-immunoprecipitation (Co-
IP) of Appl-FLAG and Vang-Myc. The tagged proteins were co-
expressed in HEK293T cells and immunoprecipitated with anti-
Myc antibody. Appl-FLAG can be precipitated upon IP of Vang.
The Co-IP in this direction is weaker than after pull-down of Appl-
Flag. (C) Co-IP of Appl-FLAG and human Vangl2-HA. Appl-
FLAG can be precipitated upon IP of human Vangl2-HA. (D) Co-
IP of APP (C99)-FLAG and Vangl2-HA. The tagged proteins
were immunoprecipitated from whole cells with anti-HA antibody.
APP (C99)-FLAG can be precipitated upon IP of human Vangl2-
HA. (E) Control co-immunoprecipitation of overexpressed Appl-
FLAG and Vangl2-HA. The proteins were separately expressed in
different cells plated in two different dishes and pooled during the
Co-IP procedure. The IP was performed with anti-FLAG and
anti-HA antibody and followed by Western blot analysis. The
proteins do not co-immunoprecipitate when expressed in different
populations of cells. (F) Co-immunoprecipitation (Co-IP) of Appl-
FLAG and Fz-GFP. Appl-FLAG can be precipitated upon IP of
Fz.
(PDF)
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